From Painful Bladder Syndrome To Losing Eyesight – The Journey To Disaster For Elmiron Patients

December 16, 2019 / 6:20 am

Imagine going to the doctor for unbearable pain, leaving with a medication that is supposed to help, and then losing your eyesight due to that medication. When you go to see a doctor for care, you never expect to undergo a treatment that could make things worse. Unfortunately, the prescription drug used to treat painful bladder syndrome, Elmiron, is now known to cause permanent eye damage. At Colson Hicks Eidson, our award-winning firm is taking patient cases in Florida and throughout the United States.

How did the Elmiron journey begin?

Interstitial cystitis is incredibly painful for patients. There is a range of symptoms that those suffering from this condition can experience. Also known as painful bladder syndrome, interstitial cystitis patients commonly suffer from the following:

  • Extreme and painful bladder pressure that gets worse as the bladder fills
  • Pain in the lower stomach, pelvis, urethra, and lower back
  • For women, pain in the vagina, vulva, or area behind the vagina
  • For men, pain in the penis, testicles, scrotum, or area behind the scrotum
  • An urgency to urinate even right after going
  • The needs to urinate more often than normal

Those who suffer from interstitial cystitis describe pain ranging from a dull ache to piercing pain. It is no wonder those who suffer from this condition or willing to take a prescription drug that promises to alleviate these symptoms.

The only FDA-approved prescription medication for interstitial cystitis is sodium pentosan polysulfate (PPS), sold as the brand name Elmiron. Made by Janssen Pharmaceuticals, those who take Elmiron have found relief from painful bladder syndrome.

What they did not know was that long-term use of this prescription drug would be linked to permanent eye damage. A flurry of research is emerging in the United States and Canada that many Elmiron patients with significant exposure to Elmiron showed noticeable eye damage.

Patients have gone from painful bladder syndrome to possible permanent eye damage, a journey they never expected. This is something they were never warned about.

To make matters worse, Elmiron has not yet been recalled by the FDA. The federal regulatory agency has not even mentioned any issues concerning this prescription drug, and across the Atlantic in the United Kingdom, the National Health Service is expanding its use of the drug.

We are going to get to work for you

If you or a loved one have been taking the prescription drug Elmiron and have suffered eye damage or any other adverse effects, seek legal assistance immediately. At Colson Hicks Eidson, our nationally-recognized firm will work to investigate your case in order to secure the compensation you deserve. This can include:

  • Coverage of any medical bills related to the defective drug
  • Recovery of income lost if you are unable to work
  • Mental anguish damages
  • Loss of enjoyment of life damages
  • Punitive damages against the company or manufacturer

When you need an Elmiron attorney throughout Florida or the United States, you can contact us for a free consultation by clicking here or by calling us at 305-476-7442.

Trending Stories

November 22, 2024

Latest Updates
and Insights from Colson

Related News & Case Studies

A federal judge in Florida denied UnitedHealthcare’s motion to dismiss a lawsuit brought by a cancer patient seeking coverage for proton beam radiation therapy to treat his tongue cancer. The patient, Carlos Morera, alleges the insurer wrongfully denied benefits under his healthcare plan, forcing him to pay approximately $195,000 out of pocket for the treatment.

Stephanie A. Casey, a partner at Colson Hicks Eidson, represents Morera and successfully argued that the case should proceed.

“We look forward to presenting the merits of this case at trial. Proton beam radiation therapy has long been recognized as the standard of care for these types of cancers,” she said.

The court’s decision allows Morera to continue his fight to recover treatment costs. Read more about this case on Law360 here.

MIAMI (November 20, 2024) – Colson Hicks Eidson has been named to the 2025 edition of the “Best Law Firms” by Best Lawyers®, recognized at both the national and metropolitan levels. Seven of the firm’s attorneys were also named to the 2025 edition of Best Lawyers® across multiple practice areas.

“We are committed to delivering exceptional representation for our clients. This continued recognition of our firm’s core practice areas highlights the success of our efforts,” said Dean C. Colson, Managing Partner of Colson Hicks Eidson.

Best Lawyers® ranks top lawyers and law firms through a peer review process, using feedback from lawyers, clients, and professional references, along with firm data. Rankings are organized into regional and national tiers.

National Tier 2

● Mass Tort Litigation / Class Actions – Plaintiffs

Metropolitan Tier 1

Miami

● Bet-the-Company Litigation
● Commercial Litigation
● Criminal Defense: White-Collar
● Insurance Law
● Mass Tort Litigation / Class Actions – Plaintiffs
● Medical Malpractice Law – Defendants
● Medical Malpractice Law – Plaintiffs
● Personal Injury Litigation – Plaintiffs
● Product Liability Litigation – Plaintiffs

Metropolitan Tier 2

Miami

● Professional Malpractice Law – Defendants

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

MIAMI (November 12, 2024) – Colson Hicks Eidson announced today that managing partner Dean Colson has been recognized in Florida Trend’s 2024 edition of the Florida 500, a publication highlighting the 500 most influential executives across various economic sectors in the state.

The publication notes that Dean’s credentials include chairing the state university system’s Board of Governors, the board of trustees for Florida International University, and the board of trustees for the University of Miami.

Dean is renowned as a top trial lawyer in the U.S. with 40 years of experience in complex civil litigation, personal injury, product liability, and professional malpractice. He has successfully represented large plaintiff classes and handled multimillion-dollar cases, including high-profile litigation such as the AeroPeru airplane crash and a Ponzi scheme settlement.

Dean has demonstrated a strong commitment to community service through various leadership roles. He has been actively involved with the Institute of Contemporary Art in Miami, supporting access to the arts. He’s also been president of the Orange Bowl Committee and chaired the Super Bowl XXIX Host Committee. He served on the Florida Commission on Ethics and chaired the Florida Supreme Court Judicial Nominating Commission. He previously served as President of the Dade County Bar Association and as a distinguished member of the Florida Bar Board of Governors. Most recently, the Coral Gables Community Foundation recognized Dean at its 2024 Annual Gala with the Education Award.

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication to forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

The U.S. Attorney’s Office for the Southern District of Florida has launched a new Whistleblower Non-Prosecution Pilot Program. It reinforces the recent efforts of the Department of Justice Criminal Division’s new Corporate Whistleblower Awards Pilot Program.

The local pilot program offers non-prosecution agreements in exchange for the early and voluntary self-disclosures of criminal conduct.  The Department’s pilot program offers financial rewards to a whistleblower who provides original and truthful information about corporate misconduct that results in a successful forfeiture.  

Both pilot programs require the prompt disclosure of truthful and complete information.   

At Colson Hicks Eidson, our attorneys have advised and represented clients across the full range of internal investigations, government inquiries, enforcement actions, whistleblower actions, and civil and criminal trials.  For further information, contact us at 305-476-7400 or info@colson.com.

MIAMI (June 24, 2024) – Colson Hicks Eidson announced today that six of its attorneys have been named in the 2024 edition of Florida Super Lawyers. Stephanie Casey, Dean Colson, Joseph J. Kalbac, Jr., Julie Braman Kane, and Curtis Miner have been named Super Lawyers. Zachary Lipshultz has been recognized as a Rising Star.

Super Lawyers uses a rigorous screening process including independent research, peer nominations, and evaluations to rate lawyers. Only 5 percent of lawyers in Florida are rated by Super Lawyers, and no more than 2.5 percent of lawyers under 40 or with fewer than 10 years of practice are selected as Rising Stars.

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

MIAMI (June 13, 2024) – Colson Hicks Eidson has been recognized as one of the top three trial law firms in Florida in the “Litigation: Mainly Plaintiffs” category by the respected Chambers and Partners USA Legal Guide for the fourth year in a row. In addition, five of the Miami-based firm’s attorneys were also ranked individually.

“These rankings highlight the commitment and hard work of our attorneys, showcasing our firm’s capability to manage diverse cases for our clients,” said Dean Colson. “As the South Florida business landscape evolves, we remain committed to serving new clients while upholding the same standard of excellence that has defined our firm for 55 years.”

Stephanie Casey, Julie Braman Kane, Curtis Miner, Roberto Martínez, and Mike Eidson were all ranked individually for their work in the “Litigation: Mainly Plaintiffs” category. Miner received the top ranking (Band 1) and Eidson was named “Senior Statesperson” in “Litigation: Mainly Plaintiffs.” Martínez was named “Senior Statesperson” in two categories: “Litigation: Mainly Plaintiffs” and “White Collar Crime and Government Investigations.”

The rankings are a result of the firm’s exceptional track record of securing multimillion-dollar judgments and settlements for its clients in areas that include commercial litigation, medical malpractice, products liability, class actions, multidistrict litigation, and aviation and automobile accidents.

To schedule a consultation, do not hesitate to contact an attorney at our law office. We have experience in a wide variety of cases for clients located throughout the nation and around the globe.

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.